INC Research ��� Raleigh, NC
www.incresearch.com ��� (919) 876-9300
key locations: Argentina, Australia, China, India, United Kingdom, and United States
contact: Neil Ferguson, executive VP, global business development ��� info@incresearch.com
Drug Life Cycle Stages:
Research & Development ��� Clinical (Phase 1, Phase 2, and Phase 3)
Main Service Areas:
Clinical
SERVICES & CAPABILITIES: Phase I - IV clinical services include: biometrics, clinical monitoring, drug safety, FSP/strategic alliances, patient recruitment/retention, project management, regulatory
affairs, and strategic consulting
THERAPEUTIC AREAS: Cardiovascular, CNS, dermatology, endocrinology, gastroenterology, immunology, infectious diseases, inflammation, oncology, ophthalmology, respiratory, and special
expertise in pediatrics and women���s health populations
���INC Research is honored to be recognized as an industry leader in delivering quality services and innovative solutions to our customers. We remain focused on driving
operational efficiencies through cutting-edge technologies that help inform strategic drug development decisions - ultimately reducing cost and increasing the value of R&D;
investments ��� in support of bringing products to market that improve world health.���
��� Jamie Macdonald, CEO
inVentiv Health Clinical (formerly PharmNet/i3) ��� Princeton, NJ ��� (609) 951-6800
key locations: More than 36 countries including Argentina, Canada, Singapore, Switzerland,
United Kingdom, and the U.S. ��� www.inventivhealthclinical.com
contact: Greg Skalicky, EVP business development ��� gregory.skalicky@inventivhealth.com
Drug Life Cycle Stages:
Research & Development ��� Clinical (Phase 1, Phase 2, and Phase 3)
Main Service Areas:
Bioanalytical, Clinical
SERVICES & CAPABILITIES: inVentive Health Clinical provides drug development services, offering therapeutically specialized capabilities for phase I-IV trials, bioanalytical services, and resourcing
from a single clinical professional to an entire functional team.
THERAPEUTIC AREAS: Neuroscience, cardiovascular, oncology, and infectious diseases
Jubilant Clinsys Inc. ��� Bedminster, NJ
key locations: Bangalore, India; Bedminster, NJ; D��sseldorf, Germany; Pradesh, India; and
Raleigh, NC ��� www.clinsys.com ��� (908) 947-7711
contact: Diana Hinton ��� dhinton@clinsys.com
Drug Life Cycle Stages:
Research & Development ��� Clinical (Phase 1, Phase 2, and Phase 3)
Main Service Areas:
Bioanalytical, Clinical
SERVICES & CAPABILITIES: Jubilant Clinsys Inc. is a full-service, global, contract research organization that provides pharmaceutical, biotechnology, and medical device companies with a full range
of services in support of phase I ��� late phase drug and device development.
THERAPEUTIC AREAS: Dermatology, oncology, neurology, respiratory, cardiovascular, ophthalmology, wound healing, central nervous system
KEY INDUSTRY PARTNERS: Large and mid-size pharmaceutical companies, biotechnology industries, medical device companies
���Jubilant Clinsys is thrilled to receive a CRO Leadership Award in the category of productivity. We have invested in hiring the ���right��� people, those who thrive in an atmosphere
of responsibility and excellence. Furthermore, we continuously evaluate our processes to improve our performance and to provide superior value for our clients. This
prestigious award validates our ongoing efforts to strive for improvements in every aspect of our client service delivery and our desire to achieve excellence in our work.���
��� Nayan Nanavati, chief executive officer
26
The CRO Leadership Awards 2013